House Rx gains $25m Series A

House Rx, a health technology platform focused on improving affordability and patient access to specialty medications, has secured $25 million in Series A financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this